Thus, caution should be taken when using the SUVmax as an alternative marker for CD147-related chemotherapy resistance, and more bench studies and clinical trials are needed before the SUVmax can be used as a reliable marker to determine the chemotherapy resistance of lung adenocarcinomas in the clinic. This evidence concerns the gene BSG and lung adenocarcinoma.